Megan Johnston started taking semaglutide, the active ingredient in several brands of weight loss drugs, last year to try to lose weight. The 38-year-old Arlington, Virginia, real estate agent said she gained 30 pounds during the pandemic, and was drinking more too. ...
impairs the brain’s associative learning capability. However, a single dose of the anti-obesity drug liraglutide restored this ability, equalizing brain activity between obese and normal-weight participants.
As the benefits of the GLP-1 receptor agonists with T2D, obesity, and cardiovascular health are becoming widely known, research into using these agents to treat other conditions has accelerated. Through these studies, potential new opportunities have risen to utilize GLP-1 receptor agonists to treat...
For example, if a couple started out in the marriage as, ‘smokers’ and later, one of the parties learned the benefits of being smoke free, he or she may decide to stop. I’ve seen this happen plenty of times with couples. Most of the time, the change occurs in the face of a p...
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review Kamil Szupryczyński, ...
Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual framework. Diabetes Obes. Metab. 2020, 22, 734–742. [Google Scholar] Li,...